Skip to content

Evaluation of a new protocol for controlling blood glucose in hospitalized patients

Evaluation of a new protocol for controlling blood glucose and comparing it with old strategies for controlling blood glucose in patients who hospitalized in infectious ward

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20130917014693N9
Enrollment
108
Registered
2019-08-15
Start date
2017-04-04
Completion date
Unknown
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Diabetes. Condition 2: Pneumonia. Condition 3: cellulitis. Condition 4: Diabetic foot infection. Diabetes mellitus due to underlying condition Streptococcus pneumoniae as the cause of diseases classified elsewhere Cellulitis of toe Personal history of diabetic foot ulcer

Interventions

Intervention 1: Intervention group: In this group the needed daily insulin calculate. This dose includes short acting insulin (Regular, Exir Company) and long action insulin (NPH, Exir Company). The p

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients with diabetes mellitus Age more than 18 years ago Patients under subcutaneous insulin regimen Patients who hospitalized in infectious diseases ward due to pneumonia, cellulitis, and diabetic foot infection

Exclusion criteria

Exclusion criteria: Pregnant women Surgical patients Patients on intravenous insulin Patients with end stage renal disease Patients on total parental nutrition Patients who did not sign the patient informed consent form

Design outcomes

Primary

MeasureTime frame
Blood glucose level. Timepoint: Every six hours. Method of measurement: Glucometer.

Secondary

MeasureTime frame
Fever. Timepoint: Every six hours. Method of measurement: Mercury Therommeter.;Durration of hospitalization. Timepoint: At discharged. Method of measurement: Patient record.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Sahraei

Shahid Beheshti University of Medical Sciences

zahra.sahraei@yahoo.com+98 21 8820 0118

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026